198P - A multicentre, international neoadjuvant (NA), randomized, double-blind phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib in patients with operable luminal breast cancer (SAFIA Trial)
| Autor: | Nabholtz, J-MA, Alsaleh, K.A., Bounedjar, A., Oukkal, M., El-Zawahry, H.M., Bouzid, K., Razek, H Abdel, Mahfouf, H., Bensalem, A., Saadeddin, A., Filali, T., Larbaoui, B., Abulkhair, O., Al-Foheidi, M., Boussen, H., ayari, J., Ghosn, M., Abdel-Aziz, N., Dabouz, F., Kullab, S. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v67-v67 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|